Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2004
09/22/2004CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent
09/22/2004CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands
09/22/2004CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
09/22/2004CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d
09/22/2004CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha
09/22/2004CN1167466C Oral medicinal preparation
09/22/2004CN1167422C Quinazoline derivatives as angiogenesis inhibitors
09/22/2004CN1167413C Aerosol ointment compositions and preparation thereof
09/22/2004CN1167412C Transdermal physiotherapeutic medicine gel
09/21/2004US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide
09/21/2004US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease
09/21/2004US6794507 Compounds that inhibit factor Xa activity
09/21/2004US6794506 Treatment of inflammatory diseases, such as asthma, alzheimer's disease, atherosclerosis, aids dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis
09/21/2004US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia
09/21/2004US6794405 Alicyclic imidazoles as H3 agents
09/21/2004US6794403 Substituted benzoxazoles as estrogenic agents
09/21/2004US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
09/21/2004US6794398 Preventive/remedies for liver diseases
09/21/2004US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794386 β-amino acid compounds as integrin antagonists
09/21/2004US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof
09/21/2004US6794380 Amide derivatives
09/21/2004US6794378 Heterocyclic compounds and medical use thereof
09/21/2004US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders
09/21/2004US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands
09/21/2004US6794150 Detecting liver disorders in mammals; obtain sample, measure amount of marker, compare to control, diagnose liver disorder
09/21/2004US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells
09/21/2004US6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists
09/21/2004CA2277947C Pyrrolidine derivatives having phospholipase a2 inhibitory activity
09/21/2004CA2273272C Immediate release drug delivery forms
09/21/2004CA2256718C Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
09/21/2004CA2241502C A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anti-inflammatory drugs
09/21/2004CA2076226C Substituted 1-pyrimidinylacetamide compounds
09/16/2004WO2004078763A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
09/16/2004WO2004078758A1 Novel fused heterocycles and uses thereof
09/16/2004WO2004078755A1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors
09/16/2004WO2004078751A1 Benzofuran derivative
09/16/2004WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists
09/16/2004WO2004078749A1 Heterocyclic urea derivatives for the treatment of pain
09/16/2004WO2004078744A2 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
09/16/2004WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent
09/16/2004WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
09/16/2004WO2004012655A3 Anti-microbial compositions and methods of using same
09/16/2004WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
09/16/2004WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen
09/16/2004WO2003092586A3 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
09/16/2004WO2003090682A3 Treatment and prevention of pulmonary conditions
09/16/2004WO2003066063A8 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
09/16/2004WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins
09/16/2004WO2003052048A3 Nucleic acid-associated proteins
09/16/2004WO2003045318A3 Manipulation of cytokine levels using cd83 gene products
09/16/2004WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto
09/16/2004WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040181062 Benzimidazole cyclooxygenase-2 inhibitor
09/16/2004US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
09/16/2004US20040181047 33 human secreted proteins
09/16/2004US20040181037 Phosphatidyl serine receptors and uses thereof
09/16/2004US20040180963 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
09/16/2004US20040180961 poorly water-soluble aceclofenac, a polymeric base selected from the group consisting of polyvinylpyrrolidone, methylcellulose, ethylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, glycerolmonostearate, carbamer and poloxamer, and a surfactant
09/16/2004US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms
09/16/2004US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system
09/16/2004US20040180926 Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions
09/16/2004US20040180924 Novel heterocyclic derivatives and medicinal use thereof
09/16/2004US20040180915 Methadone-containing compositions for parenteral administration and method of use thereof
09/16/2004US20040180914 5-Cyano-2-aminopyrimidine derivatives
09/16/2004US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
09/16/2004US20040180899 tyrosine kinase inhibitors
09/16/2004US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
09/16/2004US20040180884 Dibenzocycloheptene compound
09/16/2004US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/16/2004US20040180836 Blocking peptide for inflammatory cell secretion
09/16/2004US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
09/16/2004US20040180396 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
09/16/2004US20040180066 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV)
09/16/2004US20040180007 Pharmaceutical chewing gum formulations
09/16/2004DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics
09/16/2004DE19804376B4 Lipidmischungen sowie deren Verwendung Lipid mixtures and their use
09/16/2004DE10310106A1 Substituierte Pyridot [1,2-a]pyrimidin-Verbindungen Substituted Pyridot [1,2-a] pyrimidine compounds
09/16/2004DE10308864A1 Neues Brauverfahren, damit gebrautes Bier und dessen Verwendung New brewing process, thus brewed beer and its use
09/16/2004CA2517847A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
09/16/2004CA2517422A1 Tetrahydropyran compounds as tachykinin antagonists
09/16/2004CA2512280A1 Benzofuran derivative
09/15/2004EP1457493A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
09/15/2004EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
09/15/2004EP1457485A1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
09/15/2004EP1457202A2 Topical formulation comprising a NSAID, preferably diclofenac, for alleviating pain/inflammation caused by herpes virus infection
09/15/2004EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
09/15/2004EP1456378A2 Il-17 like molecules and uses thereof
09/15/2004EP1456365A2 Protein modification and maintenance molecules
09/15/2004EP1456241A2 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs
09/15/2004EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
09/15/2004EP1456214A2 Improvements in pharmaceutical compositions
09/15/2004EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof
09/15/2004EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme
09/15/2004EP1456205A1 Imidazoquinoline derivatives
09/15/2004EP1456204A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands
09/15/2004EP1456202A1 Benzothiazoles
09/15/2004EP1456201A1 Benzhydryl derivatives